[ad_1]
A great day for science and humanity .. This is what Dr. Albert Burla, President and CEO of the company, said PfizerA tribute to the results of the experiment, after the vaccine against the Corona virus that Pfizer is developing has shown its effectiveness by 90%, according to what published by the siteCNBCAmerican.
This was announced by the giant American pharmaceutical company Pfizer It is a German biotechnology company BioNTech Their coronavirus vaccine is over 90% effective in preventing HIV COVID-19 Among those with no evidence of a previous injury, hailing the development as a “big day for science and humanity”.
Two companies announced it Pfizer IS BioNTech Recently the split of the case between vaccinated individuals and those who received a placebo indicates that the vaccine efficacy rate is greater than 90% seven days after the second dose, which means protection from COVID-19 It is achieved 28 days after the initial vaccination, which consists of a two-dose schedule.
The company president said Pfizer And its CEO is Dr. Albert Burla for Meg Terrell from CNBC In a program Squawk Box: “I think we can see the light at the end of the tunnel.”
This comes at a time when drug manufacturers and research centers around the world are rushing to provide a safe and effective vaccine in an effort to end the Corona virus pandemic that has killed more than 1.25 million people. all over the world.
Scientists hope to have at least 75 percent effective coronavirus vaccine, while White House coronavirus consultant Dr. Anthony Fauci previously said a 50 percent or 60 percent effective vaccine would be acceptable.
The results were based on the first interim efficacy analysis conducted by an external and independent data control panel from the Phase 3 clinical trial. An independent expert panel oversees the US clinical trials to ensure the safety of the participants.
The analysis evaluated 94 confirmed infections with COVID-19 Among the participants in the experiment a total of 43,538 participants. Two companies said Pfizer IS BioNTech The division of the condition between vaccinated individuals and those who received the placebo indicates that the vaccine efficacy rate is greater than 90% seven days after the second dose.
This means protection from COVID-19 It is achieved 28 days after the initial vaccination, which consists of a two-dose schedule.
The final efficacy rate of the final vaccine may vary as additional data and safety are collected.
Prank said in a statement: “The first batch of results from a vaccine trial COVID-19 For the third phase, it provides preliminary evidence of our vaccine’s preventative capacity COVID-19“.
Prank continued: “We have reached this milestone in our vaccine development program at a time the world needs most, as infection rates have set new records, hospitals are approaching capacity and economies are struggling. to reopen “.
“With today’s news, we are nearing an important step in providing people around the world with a much-needed result to help end this global health crisis. We look forward to sharing more data on effectiveness and on security generated by thousands of participants in the coming weeks “.
The company said Pfizer IS BioNTech Nearly 42% of global study participants have ethnic and diverse backgrounds, adding that no serious safety concerns have been reported so far.
The companies said they plan to file an emergency use permit with the U.S. Food and Drug Administration shortly after obtaining two months of data, which is currently pending for the third week of November.
Based on current projections, two companies are expected Pfizer IS BioNTech Production of up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.
The companies have stated that they intend to submit data from the third full phase of the trial, which began on July 27, for scientific publication for peer review.
US officials and scientists hope it’s a vaccine to be prevented COVID-19 Ready in the first half of 2021 – 12-18 months since scientists first identified the Coronavirus and mapped its genetic sequence.
.
[ad_2]
Source link
